Mercator MedSystems: Shenzhen Xinlitai completed the acquisition of 9% of Mercator, a US cardiovascular interventional medical device company

Mercator is mainly engaged in the research and development, production and sales of high-end cardiovascular interventional medical devices. The core patented technology is “targeted drug microneedle delivery system”.